“We estimated that we captured somewhere between 80% and 90% of FMTs administered during this period within our data set,” study author Michael H. Woodworth, MD, MSc, assistant professor, Emory University, said. “We then linked these two datasets for recurrent C difficile infection, and FMT receipt to evaluate for potential disparities, and estimate the frequency of CDI, FMT receipt using the SPI data that is provided by the CDC.”
Woodworth noted some takeaways.
“We were surprised to find that only 7% of patients with recurrent C difficile infection were treated with an FMT overall, but maybe more surprising was that only 40% of black patients were as likely to be treated with FMT,” Woodworth said. “After adjusting for other factors, like insurance. We used a CDC dataset called the social vulnerability index, or SPI, which ranks several variables of social vulnerability at the level of census tracts. And we found that SPI variables of housing and transportation, in particular were also strong predictors of FMT received.”
Contagion spoke to Woodworth who offered further insights on the study.